Sutro Biopharma, Inc. (STRO)

NGM – Real Time Price. Currency in USD

18.41

-6.63 (-26.50%)

Market open: Aug 12, 2026, 10:51 AM EDT

25.04

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

102M

62M

154M

68M

Cost of goods sold

-7M

-8M

Gross Profit

95M

55M

147M

59M

Operating expenses (excl. COGS)

-200M

-293M

-236M

-188M

Operating Income

-105M

-238M

-89M

-129M

Non-operating income, total

-86M

13M

677K

12M

Pretax income

-191M

-225M

-89M

-117M

Equity in earnings

Taxes

93K

-2M

-18M

-3M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-191M

-227M

-107M

-119M

Discontinued operations

Net income

-191M

-227M

-107M

-119M

Dilution adjustment

Preferred dividends

Sutro Biopharma, Inc. (STRO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Sutro Biopharma, Inc. (STRO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Sutro Biopharma, Inc. (STRO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Sutro Biopharma, Inc. (STRO)

Income Statement (Annual)

Income Statement (Annual)